We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
One-quarter of the institutional review boards (IRBs) that oversee clinical research at medical schools have no written policy on potential conflicts of interest among members, and only one in five systematically collects information about members’ potential conflicts of interest, according to a recent study.
The number of children receiving prescriptions for antidepressants dropped following warnings from the FDA about the increased risk of suicidal behavior associated with the drugs, according to a new study.
A new analysis of previously conducted studies showed no increase in coronary heart disease for women in their 50s who take hormone therapies close the start of menopause, according to an article in The Journal of the American Medical Association (JAMA).
The number of children receiving prescriptions for antidepressants dropped following warnings from the FDA about the increased risk of suicidal behavior associated with the drugs, according to a new study.
Bristol-Myers Squibb (BMS) is cooperating with federal trade officials in a new civil probe launched last week related to the patent litigation settlement over generic Plavix, the company said.
Drugmakers spent $155 million lobbying Congress between January 2005 and June 2006, trying to influence legislation on Medicare, drug importation and patent protection, according to a study by The Center for Public Integrity.
Omnicare has entered into a contract with Cardinal Health’s repackaging unit following the long-term care pharmacy’s closure of its Heartland operation, the companies recently announced.
One-quarter of the institutional review boards (IRBs) that oversee clinical research at medical schools have no written policy on potential conflicts of interest among members, and only one in five systematically collects information about members’ potential conflicts of interest, according to a recent study.
Medical device companies "overwhelmingly" accept AdvaMed's Code of Ethics on Interactions with Health Care Professionals, but they face "significant challenges" in implementing the code, according to a white paper released March 29.
Drug company spending on direct-to-consumer (DTC) advertising will continue to increase, although drugmakers are worried about potential legislation that would restrict the advertisements, research company Guideline said in a new report.